Cite
HARVARD Citation
Shkalim Zemer, V. et al. (2016). Factors Affecting the Upper Limit of the Methotrexate (MTX) CSF Levels Achievable in Children With Brain Tumors Treated With High-dose Intravenous MTX. Journal of pediatric hematology/oncology. 38 (7), p. . [Online].